These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7999792)

  • 1. Topoisomerase I is differently phosphorylated in two sublines of L5178Y mouse lymphoma cells.
    Staron K; Kowalska-Loth B; Zabek J; Czerwinski RM; Nieznanski K; Szumiel I
    Biochim Biophys Acta; 1995 Jan; 1260(1):35-42. PubMed ID: 7999792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of topoisomerase I in L5178Y-S cells is associated with poly(ADP-ribose) metabolism.
    Staron K; Kowalska-Loth B; Nieznanski K; Szumiel I
    Carcinogenesis; 1996 Mar; 17(3):383-7. PubMed ID: 8631120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancy between the initial DNA damage and cell survival after camptothecin treatment in two murine lymphoma L5178Y sublines.
    Gradzka I; Szumiel I
    Cell Biochem Funct; 1996 Sep; 14(3):163-71. PubMed ID: 8888569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
    Lanza A; Tornaletti S; Stefanini M; Evans HH; Ricanati M; Astaldi Ricotti GC; Pedrini AM
    Carcinogenesis; 1993 Sep; 14(9):1759-63. PubMed ID: 8403196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced sensitivity to camptothecin of topoisomerase I from a L5178Y mouse lymphoma subline sensitive to X-radiation.
    Kowalska-Loth B; Staron K; Buraczewska I; Szumiel I; Kapiszewska M; Lange CS
    Biochim Biophys Acta; 1993 Feb; 1172(1-2):117-23. PubMed ID: 8382526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKA controls a level of topoisomerase I mRNA in mouse L5178Y lymphoma cells treated with db-cAMP.
    Czerwinski RM; Nieznanski K; Sochanowicz B; Staron K
    Mol Biol Rep; 1994 Mar; 19(2):93-7. PubMed ID: 8072495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sensitivity to camptothecin of DNA topoisomerase I in L5178Y-S lymphoma cells.
    Staron K; Kowalska-Loth B; Szumiel I
    Carcinogenesis; 1994 Dec; 15(12):2953-5. PubMed ID: 8001262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of topoisomerase I-targeted drugs on radiation response of L5178Y sublines differentially radiation and drug sensitive.
    Szumiel I; Buraczewska I; Gradzka I; Gasinska A
    Int J Radiat Biol; 1995 Apr; 67(4):441-8. PubMed ID: 7738407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA repair, cell cycle progression and cell death following camptothecin treatment in two murine lymphoma L5178Y sublines.
    Gradzka I; Skierski J; Szumiel I
    Cell Biochem Funct; 1998 Dec; 16(4):239-52. PubMed ID: 9857486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the effect of camptothecin in x-irradiated L5178Y-R and L5178Y-S cells by benzamide.
    Gradzka I; Iwaneńko T; Kruszewski M; Szumiel I; Kapiszewska M; Lange CS; Afanasjev G
    Radiat Environ Biophys; 1996 Aug; 35(3):185-91. PubMed ID: 8880961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity to inhibitors of type II topoisomerases from mouse L5178Y lymphoma strains that are resistant or sensitive to X-radiation.
    Staron K; Kowalska-Loth B; Szumiel I; Buraczewska I
    Mutat Res; 1993 Feb; 285(2):175-9. PubMed ID: 7678889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of a deletion mutant of DNA topoisomerase I mRNA in a camptothecin-resistant subline of human colon carcinoma.
    Yanase K; Sugimoto Y; Tsukahara S; Oh-Hara T; Andoh T; Tsuruo T
    Jpn J Cancer Res; 2000 May; 91(5):551-9. PubMed ID: 10835501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib ("Iressa") and the DNA topoisomerase I inhibitor CPT-11 (irinotecan) in human colorectal cancer cells.
    Koizumi F; Kanzawa F; Ueda Y; Koh Y; Tsukiyama S; Taguchi F; Tamura T; Saijo N; Nishio K
    Int J Cancer; 2004 Jan; 108(3):464-72. PubMed ID: 14648715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content.
    Eng WK; McCabe FL; Tan KB; Mattern MR; Hofmann GA; Woessner RD; Hertzberg RP; Johnson RK
    Mol Pharmacol; 1990 Oct; 38(4):471-80. PubMed ID: 2172765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered phosphorylation of topoisomerase I following overexpression in an ovarian cancer cell line.
    St-Amant C; Lussier S; Lehoux J; Laberge RM; Boissonneault G
    Biochem Cell Biol; 2006 Feb; 84(1):55-66. PubMed ID: 16462890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered topoisomerase I expression in two subclones of human CEM leukemia selected for resistance to camptothecin.
    Kapoor R; Slade DL; Fujimori A; Pommier Y; Harker WG
    Oncol Res; 1995; 7(2):83-95. PubMed ID: 7579731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Xenopus laevis DNA topoisomerase I activity by phosphorylation in vitro.
    Kaiserman HB; Ingebritsen TS; Benbow RM
    Biochemistry; 1988 May; 27(9):3216-22. PubMed ID: 2839226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content.
    Woessner RD; Eng WK; Hofmann GA; Rieman DJ; McCabe FL; Hertzberg RP; Mattern MR; Tan KB; Johnson RK
    Oncol Res; 1992; 4(11-12):481-8. PubMed ID: 1338578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response of L5178Y lymphoma sublines to oxidative stress: antioxidant defence, iron content and nuclear translocation of the p65 subunit of NF-kappaB.
    Bouzyk E; Gradzka I; Iwaneńko T; Kruszewski M; Sochanowicz B; Szumiel I
    Acta Biochim Pol; 2000; 47(4):881-8. PubMed ID: 11996111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly ADP-ribosylation in two L5178Y murine lymphoma sublines differentially sensitive to DNA-damaging agents.
    Kleczkowska HE; Malanga M; Szumiel I; Althaus FR
    Int J Radiat Biol; 2002 Jun; 78(6):527-34. PubMed ID: 12065056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.